Clinical Trial

Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints

Name: Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints — clinical trial record (NCT06616571)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Record status

This record was last updated September 27, 2024 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.

Summary

The goal of this real-world study is to compare the efficacy and safety of QL0605 administered 24 hours and 48 hours after chemotherapy in breast cancer patients.

Trial Details

NCT Number	NCT06616571
Lead Sponsor	Qilu Pharmaceutical Co., Ltd.
Conditions	Chemotherapy-Induced Febrile Neutropenia
Enrollment	336 participants
Start Date	2024-09-19
Primary Completion	2025-12-30 (estimated)
Study Completion	2025-12-30 (estimated)
Updated on ClinicalTrials.gov	2024-09-27